Literature DB >> 8295211

3-substituted thieno[2,3-b][1,4]thiazine-6-sulfonamides. A novel class of topically active carbonic anhydrase inhibitors.

C A Hunt1, P J Mallorga, S R Michelson, H Schwam, J M Sondey, R L Smith, M F Sugrue, K L Shepard.   

Abstract

3-Aminoalkyl derivatives of thieno[2,3-b][1,4]thiazine-6-sulfonamide were prepared for evaluation as topically active ocular hypotensive agents. The compounds described were found to be excellent in vitro inhibitors of carbonic anhydrase II and in vivo to lower intraocular pressure in three rabbit models of ocular hypertension. Compounds 20A, 20B, and 20C met the requirement of formulation as a 1% solution at pH 5.2, but none of the compounds described exhibited greater activity in the normotensive albino rabbit, the alpha-chymotrypsin-treated albino rabbit, or the normotensive pigmented rabbit than MK-927 or MK-507, the present clinical candidates.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8295211     DOI: 10.1021/jm00028a006

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

Review 1.  Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding.

Authors:  Vijay M Krishnamurthy; George K Kaufman; Adam R Urbach; Irina Gitlin; Katherine L Gudiksen; Douglas B Weibel; George M Whitesides
Journal:  Chem Rev       Date:  2008-03       Impact factor: 60.622

2.  Tritium NMR studies of the human carbonic anhydrase I-benzenesulfonamide complex.

Authors:  A S Culf; J T Gerig; P G Williams
Journal:  J Biomol NMR       Date:  1997-10       Impact factor: 2.835

3.  Effect of the location of hydrogen abstraction on the fragmentation of diuretics in negative electrospray ionization mass spectrometry.

Authors:  Mario Thevis; Wilhelm Schänzer; Hans Schmickler
Journal:  J Am Soc Mass Spectrom       Date:  2003-06       Impact factor: 3.109

4.  Synthesis, Antibacterial and Lipoxygenase Inhibition Studies of N-(Alkyl/aralkyl)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-methylbenzenesulfonamides.

Authors:  Muhammad Athar Abbasi; Aziz-Ur Rehman; Sabahat Z Siddiqui; Anam Sheeza; Sumaira Nazir; Irshad Ahmad; Rabia Malik; Syed Aa Shah
Journal:  Turk J Pharm Sci       Date:  2017-04-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.